Featured Article

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Call to Action Issued to Address Ongoing Osteoporosis Treatment Crisis

Kenneth Saag, MD, president of the National Osteoporosis Foundation (NOF), co-chair of the National Bone Health Alliance, and Rheumatology Advisor advisory board member, reports on the recent changes that have led to the current state of osteoporosis treatment in the US.

Latest News

Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores

Leg Positioning During Lumbar DXA Does Not Impact Trabecular Bone Scores

Researchers evaluated trabecular bone scores in 114 women during either "legs up" or "legs down" dual energy x-ray absorptiometry scans.

Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?

Should Trabecular Bone Score Be Used to Predict Fragility Fracture Risk in T1D?

Fragility fracture risk increased with age and decreased with higher BMD in patients with type 1 diabetes.

DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography

DXA for Pediatric Bone Age Assessment Yields Similar Results vs Traditional Radiography

Dual-energy X-ray absorptiometry for bone age assessment complements traditional radiologic assessment.

Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence

Remote Osteoporosis Specialist Mentoring Program Improves Physician Self-Confidence

The Bone Health TeleECHO Clinic helps mentor healthcare professionals and improves osteoporosis care in underserved communities.

The Handoff: Your Week in Rheumatology News - 4/14/17

The Handoff: Your Week in Rheumatology News - 4/14/17

This week, a phase III trial for investigational drug voclosporin for lupus nephritis treatment was approved, prolonged insomnia may lead to less robust bone formation — causing osteoporosis and bone fractures — and researchers found that women who drink a moderate amount of alcohol daily have a reduced risk of developing systemic lupus erythmatosus.

Postmenopause Osteoporosis Drug Denosumab Demonstrates Long-term Safety

Postmenopause Osteoporosis Drug Denosumab Demonstrates Long-term Safety

Three-year fracture study examines the effects of osteoporosis drug denosumab on fractures, bone mineral density, and bone turnover markers in postmenopausal women with osteoporosis.

Anti-fracture Therapy Prevents Bone Loss in Women After Critical Illness

Anti-fracture Therapy Prevents Bone Loss in Women After Critical Illness

Prospective observational cohort study examines association between post-ICU administration of anti-fracture therapy or glucocorticoids and longitudinal changes in bone mineral density.

Bone and Basal Metabolism Linked to Vitamin D Levels

Bone and Basal Metabolism Linked to Vitamin D Levels

For postmenopausal women with type 2 diabetes mellitus, the correlation between bone and basal metabolism depends on serum 25-hyroxyvitamin D levels.

Hypophosphatasia Associated With Significant Fracture Burden and Psychological Comorbidities

Hypophosphatasia Associated With Significant Fracture Burden and Psychological Comorbidities

Study used the University of Utah Health Care electronic health record (EHR) database, which contained data from 1.6 million patients.

Testosterone Treatment Increases Bone Mineral Density and Strength in Older Men

Testosterone Treatment Increases Bone Mineral Density and Strength in Older Men

Testosterone treatments help improve volumetric bone mineral density and bone strength in elderly men with low testosterone.

Sign Up for Free e-newsletters